The molecular basis of retinal ganglion cell death in glaucoma.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Progress in retinal and eye research

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.preteyeres.2011.11.002PMID 22155051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of tumour necrosis factor‐alpha ‐308 G/A polymorphism with primary open‐angle glaucoma

  2012cited by this paper
• Caspase inhibitors protect against NMDA‐mediated retinal ganglion cell death

  2011cited by this paper
• Post-Injury Delivery of rAAV2-CNTF Combined with Short-Term Pharmacotherapy Is Neuroprotective and Promotes Extensive Axonal Regeneration after Optic Nerve Trauma

  2011cited by this paper
• Investigation of the association between SLC1A3 gene polymorphisms and normal tension glaucoma

  2011cited by this paper
• Ocular Application of Nerve Growth Factor Protects Degenerating Retinal Ganglion Cells in a Rat Model of Glaucoma

  2011cited by this paper
• A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

  2011cited by this paper
• Early microglia activation in a mouse model of chronic glaucoma

  2011cited by this paper
• Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma.

  2011cited by this paper
• Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults

  2011cited by this paper
• Endothelin, astrocytes and glaucoma.

  2011cited by this paper
• Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma

  2011cited by this paper
• Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension

  2011cited by this paper
• Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline

  2011cited by this paper
• Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

  2011cited by this paper
• The p53 Activators ASPP1 and ASPP2 Regulate Retinal Ganglion Cell Death In Vivo Via Regulation of Fas and Puma

  2011cited by this paper
• [Autoimmunity and glaucoma].

  2011cited by this paper
• Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma.

  2011cited by this paper
• Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.

  2011cited by this paper
• Retinal ganglion cell loss in superoxide dismutase 1 deficiency.

  2011cited by this paper
• Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death

  2011cited by this paper
• Early gene expression changes in the retinal ganglion cell layer of a rat glaucoma model.

  2011cited by this paper
• Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma.

  2011cited by this paper
• Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.

  2011cited by this paper
• Ocular neuroprotection by siRNA targeting caspase-2

  2011cited by this paper
• Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions.

  2011cited by this paper
• JNK-dependent JUN Signaling Is Critical To Retinal Ganglion Cell Death After Axonal Injury

  2011cited by this paper
• Retinal ganglion cell gene therapy and visual system repair.

  2011cited by this paper
• During glaucoma, alpha2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection.

  2011cited by this paper
• Complement Protein C1q-Mediated Neuroprotection Is Correlated with Regulation of Neuronal Gene and MicroRNA Expression

  2011cited by this paper
• A cell‐permeable phosphine‐borane complex delays retinal ganglion cell death after axonal injury through activation of the pro‐survival extracellular signal‐regulated kinases 1/2 pathway

  2011cited by this paper
• Tumor Necrosis Factor-α and Calcium Permeable AMPA Receptors Mediate Retinal Ganglion Cell Death in Experimental Glaucoma

  2011cited by this paper
• Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma

  2011cited by this paper
• Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease

  2011cited by this paper
• Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury.

  2010cited by this paper
• Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75NTR Activity Is Neurotoxic through a Paracrine Mechanism*

  2010cited by this paper
• Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma.

  2010cited by this paper
• A single nucleotide polymorphism in the Bax gene promoter affects transcription and influences retinal ganglion cell death

  2010cited by this paper
• Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma.

  2010cited by this paper
• Susceptibility to N-methyl-d-aspartate toxicity in morphological and functional types of cat retinal ganglion cells

  2010cited by this paper
• Hypoxia Inducible Factor-1α (HIF-1α) and Some HIF-1 Target Genes are Elevated in Experimental Glaucoma

  2010cited by this paper
• In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death.

  2010cited by this paper
• Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss

  2010cited by this paper
• A glycine site‐specific NMDA receptor antagonist protects retina ganglion cells from ischemic injury by modulating apoptotic cascades

  2010cited by this paper
• ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma

  2010cited by this paper
• IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer

  2010cited by this paper
• ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway

  2010cited by this paper
• Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma.

  2010cited by this paper
• Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration.

  2010cited by this paper
• Mechanisms and functions of p38 MAPK signalling.

  2010cited by this paper
• Global gene expression changes in rat retinal ganglion cells in experimental glaucoma.

  2010cited by this paper
• Cellular inhibitor of apoptosis (cIAP1) is down-regulated during retinal ganglion cell (RGC) maturation.

  2010cited by this paper
• AMPA‐receptor trafficking and injury‐induced cell death

  2010cited by this paper
• Metabolic Vulnerability Disposes Retinal Ganglion Cell Axons to Dysfunction in a Model of Glaucomatous Degeneration

  2010cited by this paper
• Complement and the central nervous system: emerging roles in development, protection and regeneration

  2010cited by this paper
• Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve.

  2010cited by this paper
• The role of the classical complement cascade in synapse loss during development and glaucoma.

  2010cited by this paper
• Variations in the rheostat model of apoptosis: what studies of retinal ganglion cell death tell us about the functions of the Bcl2 family proteins.

  2010cited by this paper
• Lost in translation: bumps in the road between bench and bedside.

  2010cited by this paper
• The p53 orchestra: Mdm2 and Mdmx set the tone.

  2010cited by this paper
• The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation

  2010cited by this paper
• Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo.

  2010cited by this paper
• Distal axonopathy with structural persistence in glaucomatous neurodegeneration

  2010cited by this paper
• Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity.

  2010cited by this paper
• Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.

  2010cited by this paper
• HspB1 (Hsp 27) Expression and Neuroprotection in the Retina

  2010cited by this paper
• Signalling mechanisms regulating axonal branching in vivo

  2010cited by this paper
• Superoxide is an associated signal for apoptosis in axonal injury.

  2010cited by this paper
• Structure, Function, and Mechanism of Thioredoxin Proteins

  2010cited by this paper
• A role for complement in glaucoma?

  2010cited by this paper
• A Novel Calpain Inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic Acid 5-Methoxy-3-oxapentyl Ester (SNJ-1945), Reduces Murine Retinal Cell Death In Vitro and In Vivo

  2010cited by this paper
• Role of the c‐Jun N‐terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition

  2010cited by this paper
• The Polycomb Group Gene Bmi1 Regulates Antioxidant Defenses in Neurons by Repressing p53 Pro-Oxidant Activity

  2009cited by this paper
• Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma.

  2009cited by this paper
• Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?

  2009cited by this paper
• Neuronal Transporters Regulate Glutamate Clearance, NMDA Receptor Activation, and Synaptic Plasticity in the Hippocampus

  2009cited by this paper
• Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

  2009cited by this paper
• Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study.

  2009cited by this paper
• Excitotoxic Death of Retinal Neurons In Vivo Occurs via a Non-Cell-Autonomous Mechanism

  2009cited by this paper
• Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.

  2009cited by this paper
• Regulation of p53 - insights into a complex process

  2009cited by this paper
• Intracellular flow in optic nerve axons: a mechanism for cell death in glaucoma.

  2009cited by this paper
• Effect of CNTF on retinal ganglion cell survival in experimental glaucoma.

  2009cited by this paper
• Primary open angle glaucoma was not found to be associated with p53 codon 72 polymorphism in a Brazilian cohort.

  2009cited by this paper
• Neuroprotection of the optic nerve in glaucoma.

  2009cited by this paper
• Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects.

  2009cited by this paper
• Synaptic Degeneration of Retinal Ganglion Cells in a Rat Ocular Hypertension Glaucoma Model

  2009cited by this paper
• Immunoregulation of retinal ganglion cell fate in glaucoma.

  2009cited by this paper
• Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma

  2009cited by this paper
• Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates

  2009cited by this paper
• Microglia: gatekeepers of central nervous system immunology

  2009cited by this paper
• Lack of association between p53 gene polymorphisms and primary open angle glaucoma in the Japanese population

  2009cited by this paper
• Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells.

  2009cited by this paper
• The roles of ASK family proteins in stress responses and diseases

  2009cited by this paper
• Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic experimental optic neuropathy.

  2009cited by this paper
• Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice

  2009cited by this paper
• Primary open angle glaucoma in a Caucasian population is associated with the p53 codon 72 polymorphism

  2009cited by this paper
• Mitochondrial Dysfunction and Glaucoma

  2009cited by this paper
• Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients

  2009cited by this paper
• Neuroprotection: extrapolating from neurologic diseases to the eye.

  2009cited by this paper
• Death and neuroprotection of retinal ganglion cells after different types of injury

  2009cited by this paper

• ELP1 Gene Augmentation Restores Visual Function in a Mouse Model of Familial Dysautonomia

  2026cites this paper
• Long-term optic nerve head microvascular impairment after acute primary angle closure: an OCTA study.

  2026cites this paper
• Prophylactic self-assembled nucleic acid hydrogel targeting retinal ganglion cell cuproptosis and microglial neuroinflammation for retinal ischemia-reperfusion injury.

  2026cites this paper
• Association of Dietary Hexadecenoic Acid Intake With Glaucoma in Adults Over 40 Years Old: A Nationally Representative Study in the United States.

  2026cites this paper
• Mettl3 promotes reprogramming and axonogenesis of induced retinal ganglion cells.

  2026cites this paper
• Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.

  2026cites this paper
• Synaptic control of retinal ganglion cell survival and axon regeneration

  2026cites this paper
• In Vitro retinal ganglion cell differentiation and enrichment under the scope: do subtypes matter?

  2026cites this paper
• Lead (Pb) exposure results in cell type specific changes in the mouse retina and optic nerve

  2025cites this paper
• Mitochondrial-Targeted HDAP2 Preserves Retinal Ganglion Cells and Increases Pressure Tolerance in DBA/2J Mice

  2025cites this paper
• Machine Learning-Derived Diverse Regulated Cell Death Patterns for Therapeutic Target Identification in Glaucoma

  2025cites this paper
• The role of RGC degeneration in the pathogenesis of glaucoma

  2025cites this paper
• Neuroprotective effects of Berberine-loaded BMSCs-apoptotic extracellular vesicles on retinal ganglion cells: therapeutic potential for glaucomatous injury

  2025cites this paper
• Tumor Necrosis Factor Alpha-Mediated Interaction Between Microglia and Müller Cells Exacerbates Retinal Ganglion Cell Damage in Experimental Glaucoma

  2025cites this paper
• Identification and validation of oxidative stress signature genes in the trabecular meshwork of glaucoma

  2025cites this paper
• Microglial Necroptosis Mediated by RIPK3 Leads to Retinal Ganglion Cell Apoptosis Through the Release of FGF2 After Ischemia/Reperfusion

  2025cites this paper
• Therapeutic potential of P2X7 receptor in retinal diseases

  2025cites this paper
• Intraocular Pressure Matters.

  2025cites this paper
• The role of microglia in glaucoma - trigger and potential target

  2025cites this paper
• Advances in Stem Cell Therapies for Ocular Diseases: Progress in Clinical Trials and Future Perspectives

  2025cites this paper
• SPG302 protects retinal ganglion cells and preserves visual function by preserving synaptic activity in a mouse model of glaucoma.

  2025cites this paper
• Lactylated histone H4K8 regulation of MFN2/Wnt signaling integrates glycolytic metabolism and Müller cell activation in the pathogenesis of glaucoma.

  2025cites this paper
• AKAP1 regulates mitochondrial and synaptic homeostasis to enable neuroprotection and repair in retinal ganglion cell degeneration

  2025cites this paper
• Selective Receptor Modulation by Truncated Neuropeptide Y (3–36) Dissociates Vasoconstriction from Neuroprotection in Experimental Glaucoma

  2025influential citation
• Assessing the relationship between different sleep traits and retinal neurodegenerative diseases: A bidirectional Mendelian randomization study

  2025cites this paper
• Stress-induced mitochondrial fragmentation in endothelial cells disrupts blood-retinal barrier integrity causing neurodegeneration

  2025cites this paper
• Endoplasmic reticulum, mitochondria, and their crosstalk in retinal ganglion cell degeneration.

  2025cites this paper
• Diabetic retinopathy from the perspective of programmed cell death: Focusing on apoptosis, pyroptosis, and necroptosis.

  2025cites this paper
• Bilirubin-polymer nanocarriers enable targeted farrerol delivery for glaucoma neuroprotection via Nrf2-mediated ferroptosis/apoptosis inhibition

  2025cites this paper
• Exploring the role of VAV2 rare variants in primary open-angle glaucoma: genetic insights and pathophysiological mechanisms

  2025cites this paper
• Advancements in Müller Glia Reprogramming: Pioneering Approaches for Retinal Neuron Regeneration

  2025cites this paper
• Co-delivery of neurotrophic factors and a zinc chelator substantially increases retinal ganglion cell survival and axon protection in the optic nerve crush model.

  2025cites this paper
• Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight

  2025cites this paper
• Platelet Factor 4 Attenuates inflammation of microglia and Protects Retinal Ganglion Cells in Retinal Excitotoxicity.

  2025cites this paper
• Zebrafish optic nerve injury results in systemic retinal ganglion cell dedifferentiation

  2025cites this paper
• Inner Plexiform Layer Substrata Are Discernible with Commercial OCT and Affected by Aging

  2025cites this paper
• High‐Efficiency Ocular Delivery of Brain‐Derived Neurotrophic Factor and Oligomycin for Neuroprotection in Glaucoma

  2025cites this paper
• Reln-Dab1 pathway mitigates retinal ganglion cell apoptosis in retinal ischemia-reperfusion injury

  2025cites this paper
• The Associations Between Glaucoma and Circadian Rhythm Sleep Disorders in California Medicare Beneficiaries.

  2025cites this paper
• Neuroprotective and intraocular pressure lowering effects of dual-functional memantine nitrate MN-08 on the experimental models of glaucoma

  2025cites this paper
• Nanozymes in the Repair of Fundus Damage.

  2025cites this paper
• PANoptosis of Retinal Ganglion Cells.

  2025cites this paper
• Plasma rich in growth factors as a treatment for ocular fundus diseases: Mapping current applications and future directions.

  2025cites this paper
• Polystyrene nanoplastics induced retinal toxicity: Size-, dose-, and developmental stage-dependent effects on human neural retina organoids.

  2025cites this paper
• Management of ocular adverse reactions to antiglaucoma medications–Survey of optometrists in Ghana

  2025cites this paper
• Mitochondrial-Targeted HDAP2 Preserves Retinal Ganglion Cells and Increases Pressure Tolerance in DBA/2J Mice

  2025cites this paper
• Effect of Coenzyme Q10 in Inhibiting Retinal Ganglion Cell Apoptosis on Glaucomatous neuro degeneration Model

  2025cites this paper
• GLIAL FIBRILLARY ACIDIC PROTEIN, AN EARLY AND SUSTAINED INDICATOR OF RETINOPATHY PROGRESSION.

  2025cites this paper
• Physiology and pathophysiology of the retinal neuroglia.

  2025cites this paper
• The Safety and Protective Effects of Intravitreal Injection of Human Adipose-Derived Mesenchymal Stem Cells in a Rat Model of Retinal Ischemia/Reperfusion Injury

  2025cites this paper
• Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review

  2025cites this paper
• The action of 7,8-dihydroxyflavone preserves retinal ganglion cell survival and visual function via the TrkB pathway in NMDA-induced retinal excitotoxicity.

  2025cites this paper
• TRPA1 exacerbates selective retinal ganglion cell vulnerability under acute ocular hypertension

  2025cites this paper
• Understanding glaucoma as astrocyte-driven neurodegeneration in the optic nerve head: an integrative clinicopathological perspective.

  2025cites this paper
• Retinal Protection of New Nutraceutical Formulation

  2025cites this paper
• Differentiation of primary retinal progenitor cells into retinal ganglion-like cells using low dose cytarabine.

  2025cites this paper
• Gut-eye axis in ophthalmic diseases: Focus on ocular neurodegeneration.

  2025cites this paper
• Efficacy of the novel MIGS implant Wistend compared to Kahook Dual Blade in the treatment of experimental ocular hypertension in rabbits

  2025cites this paper
• FABP5 regulates ROS‐NLRP3 inflammasome in glutamate‐induced retinal excitotoxic glaucomatous model

  2025cites this paper
• TAT-N24 enhances retinal ganglion cell survival by suppressing ZBP1-PANoptosome-mediated PANoptosis in an acute glaucoma mouse model.

  2025cites this paper
• Bushen-Huoxue-Mingmu-Formula attenuates pressurization-induced retinal ganglion cell damage by reducing mitochondrial autophagy through the inhibition of the Pink1/Parkin pathway

  2025cites this paper
• Stress-induced mitochondrial fragmentation in endothelial cells disrupts blood-retinal barrier integrity causing neurodegeneration.

  2025cites this paper
• SVM-Based Optical Detection of Retinal Ganglion Cell Apoptosis

  2025cites this paper
• Transfer of Mitochondria from Healthy Stem Cells to Injured Cells in Stroke with Retinal Impairments.

  2025cites this paper
• LCN2 deficiency mitigates the neuroinflammatory damage following acute glaucoma

  2025cites this paper
• Damage and repair in retinal degenerative diseases: Molecular basis through clinical translation

  2025cites this paper
• Premacular membranes and glaucoma: a review of clinical and therapeutic considerations

  2025cites this paper
• Topical Administration of Mucoadhesive Liposomes-Epoetin-β for Targeting the Ocular Posterior Segment.

  2025cites this paper
• Sustained Experimental Myopia Exacerbates the Effect of Eye Growth on Retinal Ganglion Cell Density and Function

  2025cites this paper
• Innovative approaches to treatment of eye diseases: advances in stem cell therapy use in ophthalmology

  2025cites this paper
• Dual lateral flow assay using quantum nanobeads for quantitative detection of BDNF and TNF-α in tears.

  2025cites this paper
• Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models

  2025cites this paper
• Neuroprotective Activity of Rasayana Formulation and Effect of Shigru Pallava Eye Drops on Intraocular Pressure as an Add-on Therapy Compared to the Standard of Care in Primary Open-Angle Glaucoma: Protocol for an Exploratory, Open-label, Two-arm Randomized Controlled Trial

  2025cites this paper
• Inhibition of cGMP‐Signalling Rescues Retinal Ganglion Cells From Axotomy‐Induced Degeneration

  2025cites this paper
• Survival and Axonal Regeneration of Retinal Ganglion Cells in a Mouse Optic Nerve Crush Model After a Cell-Based Intravitreal Co-Administration of Ciliary Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor at Different Post-Lesion Time Points

  2025cites this paper
• Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension

  2025cites this paper
• Bezafibrate was unsuccessful to treat leber hereditary optic neuropathy

  2025cites this paper
• Mapping key trends, relationships, and molecular pathways for neuroprotection in glaucoma: a bibliometric approach.

  2025influential citation
• The Mitochondria-Targeted Peptide HDAP2 Reduces Mitochondrial Loss and Retinal Ganglion Cell Degeneration After Optic Nerve Injury

  2025cites this paper
• Dual role of microglia in glaucoma: Regulation of neuroinflammation and neuroregeneration.

  2025cites this paper
• TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension

  2025cites this paper
• Central Contrast Sensitivity as an Outcome Measure in Randomized Controlled Trials in Glaucoma—A Systematic Review

  2025cites this paper
• Retinal Vessel Diameter Reductions Are Associated with Retinal Ganglion Cell Dysfunction, Thinning of the Ganglion Cell and Inner Plexiform Layers, and Decreased Visual Field Global Indices in Glaucoma Suspects

  2025cites this paper
• Mechanobiology in the eye

  2025cites this paper
• Antioxidant-rich diets and glaucoma prevention: Insights from dietary oxidative balance scores in NHANES 2005–2008

  2025cites this paper
• Unveiling the P2X7 receptor: Exploring its mechanisms, pathogenic role in ocular diseases, and emerging therapeutic potential.

  2025cites this paper
• Protective Effects of Lipoxin A4 and B4 Signaling on the Inner Retina in a Mouse Model of Experimental Glaucoma

  2024cites this paper
• The Healthy and Diseased Retina Seen through Neuron–Glia Interactions

  2024cites this paper
• Retinal Ganglion Cell Apoptosis via Downregulating Survivin by Protocadherin 7 Overexpression

  2024cites this paper
• Modeling of Retina and Optic Nerve Ischemia–Reperfusion Injury through Hypoxia–Reoxygenation in Human Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells

  2024cites this paper
• Aldose reductase is a potential therapeutic target for neurodegeneration.

  2024cites this paper
• Cholesterol and oxysterols in retinal neuron-glia interactions: relevance for glaucoma

  2024cites this paper
• Intravitreal Resveratrol as Anti Apoptotic Agent Against Retinal Ganglion Cell Loss in Ischemic Reperfusion Injury

  2024cites this paper
• Are Macula or Optic Nerve Head Structures Better at Diagnosing Glaucoma? An Answer Using Artificial Intelligence and Wide-Field Optical Coherence Tomography

  2024cites this paper
• Changes in Optic Nerve Head Blood Flow During Horizontal Ocular Duction

  2024cites this paper
• AIBP: A New Safeguard against Glaucomatous Neuroinflammation

  2024cites this paper
• Protective effects of different exercise modalities on oxidative stress in animal models of high intraocular pressure and diabetes.

  2024cites this paper
• Potential therapeutic effects of milk thistle (Silybum marianum) in eye diseases, a scoping review

  2024cites this paper
• Retinal degenerative diseases: role of dietary supplements in retinal health

  2024cites this paper
• Fluorescent identification of axons, dendrites and soma of neuronal retinal ganglion cells with a genetic marker as a tool for facilitating the study of neurodegeneration

  2024cites this paper